Albion Financial Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,000
Closed -$191K 524
2023
Q4
$191K Hold
1,000
0.02% 183
2023
Q3
$199K Hold
1,000
0.02% 164
2023
Q2
$285K Hold
1,000
0.03% 156
2023
Q1
$217K Hold
1,000
0.02% 159
2022
Q4
$206K Hold
1,000
0.02% 159
2022
Q3
$278K Hold
1,000
0.03% 151
2022
Q2
$191K Hold
1,000
0.02% 168
2022
Q1
$207K Hold
1,000
0.02% 195
2021
Q4
$178K Hold
1,000
0.01% 219
2021
Q3
$206K Hold
1,000
0.02% 183
2021
Q2
$190K Buy
+1,000
New +$164K 0.02% 190
2020
Q4
$104K Buy
+1,000
New +$86.6K 0.01% 212

Other funds holding SWAV

Albion Financial Group's SWAV Position: Q1 2024 in Review

Albion Financial Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,000 shares — an estimated $191K sold.

Albion Financial Group first reported a position in SWAV in Q4 2020 and held it in 12 quarters. The position peaked at $285K in Q2 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Albion Financial Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Albion Financial Group sold 1,000 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $191K.
  • Albion Financial Group first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 12 quarters.
  • Albion Financial Group's Shockwave Medical, Inc. Common Stock position peaked at $285K in Q2 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Albion Financial Group's 13F filing for Q1 2024, filed 19 Apr 2024.